$650 Million Settlement: Pradaxa Case Settled for $650 Million


The U.S. litigation regarding Pradaxa has been settled for the hefty amount of $650 million. The fact was ceded by Boehringer Ingelheim. Pradaxa stands for dabigatran etexilate mesylate. The...

Problems Continue Despite Gains In Oral Anticoagulant Use


Although significant progress has been made in recent years, a new survey from the European Society of Cardiology finds that there are still too many atrial fibrillation patients who are not taking...